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ORIGINAL RESEARCH

Correlation between Medication
Administration–Related Errors in Patients with
Parkinson Disease and Timing of Pharmacy-Led
Best Possible Medication Histories
Emily Cowley, Michael R Miller, Charles Yin, and Lynne Kelly
Can J Hosp Pharm. 2021;74(1):15-20
ABSTRACT

RÉSUMÉ

Background: Poor prescribing and incomplete medication administration
have been linked to increased lengths of hospitalization for patients with
Parkinson disease. The Institute for Safe Medication Practices (ISMP) has
recommended that patients with Parkinson disease receive a pharmacy
consultation within 2 h of admission to hospital.

Contexte : La mauvaise prescription et l’administration incomplète de
médicaments ont été liées à une augmentation de la durée du séjour à
l’hôpital des patients atteints de la maladie de Parkinson. L’Institute for Safe
Medication Practices (ISMP) a recommandé que les patients atteints de la
maladie de Parkinson obtiennent une consultation en pharmacie dans les
2 heures après leur admission à l’hôpital.

Objectives: To examine whether the time for a pharmacy team member
to obtain a best possible medication history (BPMH) was associated with
administration-related medication errors. The primary outcome was the
proportion of doses with a medication error during a patient’s admission
in relation to the time to completion of the initial BPMH by a registered
pharmacist (RPh) or registered pharmacy technician (RPhT). The secondary
objective was to compare the proportion of doses with a medication error
in relation to whether the BPMH was completed by an RPh or an RPhT.
Methods: This retrospective chart review involved patients with
Parkinson disease who were admitted to the medicine services at London
Health Sciences Centre from September 30, 2014, to September 30, 2018.
Patients were included if they had Parkinson disease and a medication
regimen that included levodopa-carbidopa. For all patients, an RPhT
or RPh conducted the initial BPMH or updated the BPMH. Pearson
correlation analysis was used to determine whether a correlation existed
between administration-related errors and completion of the BPMH by
a pharmacy staff member.
Results: A total of 84 patients with 104 admissions were included. There
was no significant correlation between the time to completion of the
initial BPMH by a pharmacy team member and the proportion of doses
with medication errors (p = 0.32). Although RPhTs completed the BPMHs
more quickly than RPhs (p < 0.001), there was no significant difference
between pharmacy team members in terms of the proportion of doses
with medication errors (p = 0.86).
Conclusions: Completing a BPMH within 2 h of a patient’s admission, as
per the ISMP recommendation, is unlikely to affect administration-related
medication errors, given that no correlation was identified. Expediting
BPMH without addressing other factors is insufficient, and initiatives are
required to improve the medication administration process.
Keywords: Parkinson disease, best possible medication history,
medication error

Objectifs : Vérifier si le temps d’attente pour l’obtention, par un membre de
l’équipe de la pharmacie, du meilleur schéma thérapeutique possible (MSTP)
était associé ou non à des erreurs de médication liées à l’administration. Le
résultat principal portait sur la proportion des doses comportant une erreur de
médication lors de l’admission d’un patient par rapport au temps nécessaire
à un pharmacien ou à un technicien en pharmacie autorisés pour réaliser le
MSTP initial. L’objectif secondaire visait à comparer la proportion des doses
comportant une erreur de médication entre un MSTP réalisé par un pharmacien
autorisé et un MSTP réalisé par un technicien en pharmacie autorisé.
Méthodes : Cet examen rétrospectif des dossiers impliquait des patients
atteints de la maladie de Parkinson ayant été admis aux services de médecine
au London Health Sciences Centre entre le 30 septembre 2014 et le
30 septembre 2018. Les patients pouvaient participer à l’étude s’ils avaient
la maladie de Parkinson et qu’ils suivaient un traitement médicamenteux
comprenant du lévodopa-carbidopa. Un pharmacien autorisé ou un
technicien en pharmacie autorisé réalisait ou actualisait le MSTP initial de
tous les patients. La corrélation de Pearson a servi à déterminer s’il existait
une corrélation entre les erreurs liées à l’administration et la réalisation du
MSTP par un membre du personnel de la pharmacie.
Résultats : Au total, 84 patients correspondant à 104 admissions ont été
inclus dans l’étude. Il n’y avait aucune corrélation importante entre le moment
de la réalisation du MSTP initial par un membre du personnel de la pharmacie
et la proportion des doses comportant des erreurs de médication (p = 0,32).
Bien que les techniciens en pharmacie autorisés aient terminé plus rapidement
leur MSTP que les pharmaciens autorisés (p < 0,001), aucune différence
importante n’a été notée entre les membres du personnel de la pharmacie en
termes de proportion des doses et d’erreur de médication (p = 0,86).
Conclusions : Il est peu probable que la réalisation d’un MSTP dans les
2 heures après l’admission d’un patient, conformément à la recommandation
de l’ISMP, ait une influence sur les erreurs de médication liées à l’administration,
vu qu’aucune corrélation n’a été décelée. Précipiter la réalisation du MSTP sans
aborder les autres facteurs ne suffit pas et des actions sont nécessaires pour
améliorer le processus d’administration des médicaments.
Mots-clés : maladie de Parkinson, meilleur schéma thérapeutique possible,
erreur de médication
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INTRODUCTION
Parkinson disease is a progressive neurodegenerative disorder marked by a constellation of clinical manifestations,
including bradykinesia, rigidity, a resting tremor, and postural instability.1 It is thought to be related to the loss of
dopaminergic neurons in the substantia nigra. Dopamine
replacement therapy is effective and represents the standard
of care for these patients.1
Over the years, there has been significant interest in the
problem of omission of doses of Parkinson disease–related
medications during hospitalization. Martinez-Ramirez and
others2 reviewed data for 212 patients with Parkinson disease over 2 years, looking at medication errors related to the
wrong time of administration, dose omission, and the use
of contraindicated medications. Patients who experienced
delayed administration had longer lengths of stay in hospital, and 20% of patients received a contraindicated dopamine
blocker. Similarly, Lertxundi and others3 examined patients
with Parkinson disease in the Basque Country and found
that medication errors were associated with increased length
of stay and a higher mortality rate. Derry and others4 examined the management of patients with Parkinson disease on
surgical wards over an 18-month period. Of the 51 patients
receiving medications for this disorder, 71% had missed
doses of their medications. Notably, 34% missed more than
10% of prescribed doses. Overall, 12% of all prescribed
medication doses for Parkinson disease were missed.4
Poor prescribing and incomplete drug administration
led to the development of the “ACT on Time” program
by Parkinson Canada to improve patients’ quality of life
and educate health care providers.5 The program provides
patients with educational materials, including a medical
alert card, a list of medications to avoid, and a diary to track
medications taken and their response, as well as information
that the patient should take when visiting the hospital.5 The
goal is to empower patients to advocate for themselves and
collaborate with health care providers to ensure that medications are provided at appropriate times. In addition, the
Institute for Safe Medication Practices (ISMP) published
recommendations for managing the care of patients with
Parkinson disease during hospitalization; these recommendations included stocking common Parkinson disease
medications to avoid delays associated with use of nonformulary medications, avoiding contraindicated medications,
and providing surgery at optimal times (earlier in the day) to
avoid delays in medication administration.6 Notably, one of
the recommendations related to expediting pharmacy consultations is to complete the best possible medication history
(BPMH) within 2 h of admission.6 There is currently a lack
of literature to support prioritizing patients with Parkinson
disease for BPMH, as part of the medication reconciliation
process, and to indicate whether the time to completion of
BPMH affects patient care.
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At the London Health Sciences Centre (LHSC), all
members of the health care team are responsible for documenting the BPMH to contribute to an effective medication
reconciliation process. Evidence from previous studies of
medication reconciliation suggests that registered pharmacists (RPhs) identify significantly more medication discrepancies and consistently document specific doses and
schedules to a greater extent than physicians and other health
care providers.7 Further research now supports the utilization of registered pharmacy technicians (RPhTs) to complete BPMHs in various areas of the hospital, as there do not
appear to be significant differences between RPhs and RPhTs
in terms of medication discrepancies identified.8 Current
evidence supports the RPhT role in the emergency department in reducing potential adverse drug events and identifying medication discrepancies.8 RPhTs have assisted in the
completion of BPMHs in the LHSC emergency department
since 2014, with priority for patients who will be admitted to
hospital. RPhTs currently exercise professional judgment to
determine which patients require an expedited BPMH.
The ISMP recommendation for completion of the BPMH
within 2 h of admission6 is a shift from current standards.
The purpose of this study was to establish whether there was
any relation between the time to completion of the BPMH
by a pharmacy team member and the proportion of doses of
medications with errors among patients with Parkinson disease. We also examined the proportion of doses with medication errors during a patient’s admission in relation to the
particular pharmacy professional who obtained the BPMH.

METHODS
This study was a retrospective review of adult patients with
Parkinson disease admitted to LHSC’s general medicine services from September 30, 2014, to September 30, 2018. Ethics approval was granted by the Office of Research Ethics and
the Western Health Research Institute (HSREB ID 113652).
Patients were eligible for inclusion if they had a diagnosis
of Parkinson disease, had a medication regimen that included
levodopa-carbidopa, and were admitted to the LHSC general
medicine services during the study period. For each qualifying admission, the BPMH had to have been performed or
updated by a pharmacy team member, specifically an RPhT
or RPh. No additional exclusion criteria were applied.
Patients were identified from a drug usage report of
levodopa-carbidopa. The electronic chart of each identified patient was accessed (through the patient’s medical record number) and then reviewed by a single author (E.C.) to
determine whether the patient met the inclusion criteria. The
electronic admission and progress notes were used to identify patients with a diagnosis of Parkinson disease as opposed
to those with other indications for levodopa-carbidopa. The
medication history “snapshot” was reviewed to determine
whether an RPhT or RPh was involved in the BPMH during
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the general medicine admission. The admission histories
were reviewed to determine whether the patient had additional admissions meeting the inclusion criteria. Appendix 1 (available from: cjhp-online.ca/index.php/cjhp/issue/
view/202) provides additional information about the data
collected from electronic charts.
Length of stay was calculated as the difference between
time of admission and time of discharge, expressed as number of days. The time of admission was collected from the
record of the emergency department encounter and represented the time of the decision to admit the patient.
The primary outcome was the proportion of doses with
medication errors during a patient’s admission in relation to
the time taken by a pharmacy team member to complete the
initial BPMH. Patients could have multiple updates to the
BPMH during their stay. The initial BPMH was defined as
the first BPMH completed and documented by a pharmacy
team member, and the final BPMH was defined as the last
BPMH completed and documented by a pharmacy team
member. The proportion of doses with medication errors
was defined as the total number of doses of antiparkinsonian medication either omitted or administered more than
60 min before or after the scheduled time, divided by the
total number of antiparkinsonian medication doses scheduled. The occurrence of errors in timing of administration
was determined by reviewing the electronic medication
administration record and evaluating whether any antiparkinsonian medications were administered at the wrong time
(i.e., > 60 min before or after the scheduled time) and/or
completely omitted. Omissions were defined as a nurse not
administering the drug when it was scheduled or a medication being recorded in the BPMH but not ordered.
The secondary outcome was the proportion of doses
with medication errors during a patient’s admission in relation to which pharmacy team member completed the BPMH.
Patients were categorized according to whether an RPhT or
RPh completed or modified the BPMH. The medication errors
identified during medication reconciliation were evaluated to
determine whether they involved antiparkinsonian agents or
other medications and whether the medications with discrepancies were included in the BPMH. Additionally, data were
collected to identify the most common reasons documented
for administration-related medication errors.
Descriptive statistics and frequencies were calculated for
continuous and categorical variables, respectively. The continuous variable related to specific errors in timing of administration. The categorical variables included whether patients
experienced a medication error and the reasons for the error.
Pearson correlation analysis was conducted to examine the
relation between the proportion of doses with errors and
the time to completion of the BPMH. The Student t test was
used to examine differences in medication errors and time
to BPMH completion between RPhTs and RPhs. Values of p
less than 0.05 were considered statistically significant.
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RESULTS
A total of 249 electronic patient charts were screened (Figure 1); 165 patients were excluded because they did not have
Parkinson disease or a pharmacy team member was not
involved in their BPMH during the qualifying admission.
Eighty-four patients met the inclusion criteria, of whom
16 patients had at least 1 additional qualifying admission.
In total, 104 admissions were included in the data analysis.
Table 1 presents the baseline characteristics for admissions that met the inclusion criteria. The mean age was
80.5 years, with approximately half of the patients being
male (54%); for 65% of the admissions, the patient resided at
home before admission to hospital. The average number of

FIGURE 1. Patient flow diagram and exclusion criteria. BPMH =

best possible medication history, PD = Parkinson disease, RPh =
registered pharmacist, RPhT = registered pharmacy technician.
TABLE 1. Baseline Characteristics
Characteristic

No. (%) of Admissionsa
(n = 104)

Age (years) (mean ± SD)

80.5 ± 10.1

Sex, male

56

(54)

No. of medical comorbidities (mean ± SD)

7 ± 2.5

No. of administrations per day (mean ± SD)

4 ± 2.2

Prior disposition
Home
Long-term care
Other

68
31
5

(65)
(30)
(5)

Initiation of BPMH
Medical resident
Registered pharmacy technician
Registered pharmacist
Other

41
28
28
7

(39)
(27)
(27)
(7)

Length of stay (days) (mean ± SD)

5.04 ± 5.9

BPMH = best possible medication history, SD = standard deviation.
aExcept where indicated otherwise. Data are based on a total of 104
admissions for 84 individual patients.
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medical comorbidities was 7. The first BPMH was completed
by a medical resident for 39% of the 104 admissions, by an
RPh for 27%, by an RPhT for 27%, and by a nurse for 7%. The
reason for admission was categorized as infection, weakness or functional decline, altered level of consciousness,
cardiovascular-related, or other. The most common reason
for admission was infection (37%), followed by weakness or
functional decline (31%) (Table 2). The mean length of stay
was 5.04 days.
The total number of doses of antiparkinsonian medications scheduled was 2984. Of these scheduled doses, 384
(12.9%) were given at the wrong time. Of the 104 admissions
included in the study, 91 (88%) included at least 1 dose that
was administered more than 60 min before or after the scheduled time, and 58 (56%) of the admissions had more than
10% of their total doses administered at the wrong time. The
most common documented reason for wrong administration time was “clinical judgment”, which encompassed 30%
of all doses administered at the wrong time (Table 3). Of the
2984 scheduled doses, 260 (8.7%) were omitted altogether.
The most common reason for omission of a dose was the
medication not being ordered in the emergency department
(Table 4). Notably, 23 patients had at least 1 antiparkinsonian medication error identified and addressed by a pharmacy team member. The most commonly documented error
involved the frequency of levodopa-carbidopa (e.g., initial
BPMH stated twice daily, but RPhT changed to 3 times daily).
The primary outcome—the proportion of doses with a
medication error during a patient’s admission in relation to
the time taken by a pharmacy team member to complete the

38

(37)

Weakness/functional decline

32

(31)

Cardiovascular

8

(8)

Altered level of consciousness

7

(7)

Bleeding-related

5

(5)

14

(13)

TABLE 3. Reason for Wrong Time of Dose Administration
Reason for Wrong
Administration Time

Delays in administration of antiparkinsonian medications
are a significant concern for patients as they navigate the
health care system. It is estimated that 3 of every 4 patients
with Parkinson disease will miss doses of their medications
TABLE 4. Reason for Dose Omission
No. (%) of Omissions
(n = 260)

Reason for Omission
Medication not ordered

No. (%) of Instances
(n = 384)

Medication unavailable
Other

149

(57)

62

(24)

8

(3)

41

(16)

Proportion of Doses with Errors

No. (%) of Admissions
(n = 104)

Infection

Other

DISCUSSION

Medication not appropriate

TABLE 2. Reason for Admission
Reason for Admission

initial BPMH—was not statistically significant (r = –0.098,
p = 0.32; Figure 2). Statistical analysis was also completed
according to the time when the final BPMH was completed
by a pharmacy team member; no correlation was identified with the proportion of doses having medication errors
(r = –0.094, p = 0.34; data not shown).
To address the secondary objective, the time to completion of the initial BPMH was compared between RPhTs
and RPhs. RPhTs completed the BPMH significantly more
quickly than RPhs: 9.6 versus 35.2 h from the time of admission (p < 0.001; Figure 3). Further analysis of the time to
completion of initial BPMH was conducted to examine
whether there was a reduction in the proportion of doses
with medication errors for patients whose BPMH was completed by an RPhT. Although RPhTs completed the BPMH
more quickly, the proportion of doses with medication
errors did not differ significantly (p = 0.86; Figure 4).

Time to BMPH Completion (h)

Clinical judgment

114

(30)

Incorrect schedule

90

(23)

FIGURE 2. Effect of time to complete initial best possible medication

Patient unavailable

53

(14)

Medication unavailable

51

(13)

Other

76

(20)

history (BPMH) on proportion of doses with a medication error.
Each data point represents a single admission. Red line represents
the 2-h mark (as recommended by the Institute for Safe Medication
Practices6). Pearson r = –0.098; p = 0.32.
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during a hospital admission.4 Without timely administration
of their medications, patients may experience worsening of
their symptoms and a prolonged length of stay.2-4 ISMP created recommendations for patients with Parkinson disease
who are admitted to hospital, including a pharmacy consultation to complete the BPMH within 2 h of admission.6 To
our knowledge, this is the first study examining the roles of
RPhs and RPhTs in completing medication reviews with the
goal of reducing medication administration–related errors.
The aim of the study was to determine whether a relation
existed between the proportion of doses with medication
administration–related errors and the time to BPMH completion by a pharmacy team member.
We found no significant correlation between the time
taken by a pharmacy team member to complete the BPMH
and the proportion of doses with medication administration–

Time to BPMH Completion (h)

p < 0.001

FIGURE 3. Time to completion of best possible medication history

Proportion of Doses with Errors

(BPMH) by registered pharmacy technicians (RPhT) and registered
pharmacists (RPh). Data are shown as means with standard errors of
the mean (based on n = 104 admissions). The p value was calculated
using an unpaired, 2-tailed Student t test.

FIGURE 4. Proportion of doses with medication errors for admissions

with best possible medication history completed by pharmacy
technicians (RPhT) or pharmacists (RPh). Data are shown as means
with standard errors of the mean (based on n = 104 admissions).
The p value was calculated using an unpaired, 2-tailed Student t test.
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related errors. On average, RPhTs completed the BPMH 9.6 h
after admission, compared with 35.2 h for RPhs. There was no
statistically significant difference in the proportion of doses
with medication administration–related errors between the
2 groups. No pharmacy team member completed the BPMH
within 2 h of admission, although for a total of 5 patients,
BPMH was completed by a health care provider outside the
pharmacy team within the recommended 2-h time frame.
Therefore, no further analysis was performed to determine
whether completion of the BPMH within 2 h of admission
made a significant difference in outcome.
This study considered 2 different types of medication
administration–related errors: errors of timing and complete omission. Timing errors were related to administration
of doses more than 60 min from the scheduled time. This
timing aligns with previous studies of Parkinson disease
and the routine practices of LHSC nurses, whereby they are
allowed 60 min before or after the scheduled dosing time to
administer any medication. The reasons for wrong timing
and dose omissions may indicate factors potentially contributing to the administration-related errors experienced
by patients with Parkinson disease. The most commonly
documented reason for incorrect timing was clinical judgment (30%), followed by an incorrect schedule (23%). When
clinical judgment was reported as the cause of incorrect timing, the administration time ranged from several minutes to
hours different from when the dose was due. However, no
additional rationale was provided and no further insight was
possible, as the electronic charting system does not require
nurses to input additional information. Incorrect scheduling
of doses reflected provision of medications at the hospital’s
standardized administration times, rather than according to
the patient’s individual schedule. The patient’s medication
schedule was inconsistently documented in the BPMH, and
this type of administration error was likely underestimated.
Without documentation of the specific home administration
schedule and manual modification, the doses are set to be
administered according to the hospital’s standard administration times. Other reasons for timing errors included
patients refusing their medications, nursing staff being busy,
and patients being designated to receive nothing by mouth.
Further education is required to ensure that health care providers input specific home schedules in the BPMH so that
the correct times can be adhered to while the patient is in
hospital. It is acknowledged that although staff education
may be beneficial, such training would need to be repeated
regularly, given the relatively low proportion of patients with
Parkinson disease who are admitted to this hospital and the
staff turnover rate.
Of the 260 doses that were omitted altogether, 57% were
not ordered during the admission process. The proportion of
all doses omitted was consistent with previous literature.2-4
Another source of this type of error was omission of doses
before the time of hospital discharge. A large proportion of
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patients missed their initial doses in the emergency department, before arriving on the general medicine floor. The
data did not capture the number of patients who might have
self-administered their medications before presenting to the
emergency department. However, to align with the “ACT on
Time” initiative, patients with Parkinson disease should be
encouraged to bring their medications with them from home,
to prevent delay within the initial hours of presentation.5
Of the 84 patients included in this study, 23 patients had
an antiparkinsonian medication error documented by either
an RPh or RPhT. Without the interventions made by the
RPhT or RPh, it is hypothesized that a larger number of
medication errors would have occurred. These interventions
included updating the hospital’s records to correctly reflect
the patient’s home administration times or frequency of
administration and the addition of agents that were missed
on the initial BPMH. The definition of “medication error”
in this study pertained to the timing and omission of doses.
This study did not assess medication errors involving different strengths of medications or the number of tablets to
be administered. In addition, we did not consider the use
of dopamine antagonists, which are contraindicated for
patients with Parkinson disease. In other studies,3,4,9 the
use of contraindicated medications was a common type of
medication error measured and has been reported to occur
in as many as one-quarter of patients. Despite the limitations resulting from the retrospective design of this study,
the data demonstrate current challenges in the medication
management of patients with Parkinson disease. No clinical
outcome data were collected, as such data were not within
the scope of the study.

CONCLUSION
Timely administration of medication to hospitalized patients
with Parkinson disease remains a challenge. A growing body
of evidence has tied delays in administration of antiparkinsonian medication to prolonged length of stay in hospital,
mortality, and worsening of the disease. ISMP published several recommendations to reduce medication administration
errors in this patient population, including expedited medication reconciliation (within 2 h). In the current study, only
5 patients had BPMH completed within this recommended
time frame. Rather than targeting a specific time frame,
efforts should be made to ensure that a high-quality review
is conducted, to facilitate the medication reconciliation
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process. Expediting the BPMH without addressing other
sources of error is insufficient, and additional initiatives are
required to improve the medication-use process.

References
1.
2.

3.

4.
5.
6.

7.
8.
9.

Fahn S, Oakes D, Shoulson I, Kieburtz K, Rudolph A, Lang A, et al.
Levodopa and the progression of Parkinson’s disease. N Engl J Med.
2004;351(24):2498-508.
Martinez-Ramirez D, Giugni JC, Little CS, Chapman JP, Ahmed B,
Monari E, et al. Missing dosages and neuroleptic usage may prolong
length of stay in hospitalized Parkinson’s disease patients. PLoS One.
2015;10(4):e0124356.
Lertxundi U, Arantxa I, Solínis MA, Domingo-Echaburu S, Hernandez R, Peral-Aguirregolita, et al. Medication errors in Parkinson’s
disease inpatients in the Basque country. Parkinsonism Relat Disord.
2017;36:57-62.
Derry CP, Shah KJ, Caie L, Counsell CE. Medication management in
people with Parkinson’s disease during surgical admissions. Postgrad
Med J. 2010;86(1016):334-7.
ACT on Time™ program. Parkinson Canada; 2018 [cited 2020 Nov 16].
Available from: https://www.parkinson.ca/resources/act-on-time/
Delayed administration and contraindicated drugs place hospitalized
Parkinson’s disease patients at risk. Institute for Safe Medication Practices; 2015 Mar 15 [cited 2020 Nov 16]. Available from: https://www
.ismp.org/resources/delayed-administration-and-contraindicated
-drugs-place-hospitalized-parkinsons-disease
Reeder TA, Mutnick A. Pharmacist- versus physician-obtained medication histories. Am J Health Syst. 2008;65(9):857-60.
Johnston R, Saulnier L, Gould O. Best possible medication history
in the emergency department: comparing pharmacy technicians and
pharmacists. Can J Hosp Pharm. 2010;63(5):359-65.
Grissinger M. Delayed administration and contraindicated drugs place
hospitalized Parkinson’s disease patients at risk. P T. 2018;43(1):10-1.

Emily Cowley, PharmD, ACPR, was, at the time of this study, a Year I
Pharmacy Resident at London Health Sciences Centre, London, Ontario. She
is now a Pharmacist with Alberta Health Services, Edmonton, Alberta.
Michael R Miller, PhD, is a Statistician with the Department of Paediatrics
and the Children’s Health Research Institute, Western University, London,
Ontario.
Charles Yin, PhD, is an MD/PhD candidate with the Schulich School of
Medicine and Dentistry, Western University, London, Ontario.
Lynne Kelly, BScPharm, ACPR, is a Pharmacist with the Victoria Hospital,
London Health Sciences Centre, London, Ontario.
Competing interests: None declared.
Address correspondence to:
Dr Emily Cowley
Pharmacy
Alberta Health Services
11220 83rd Avenue NW
Edmonton AB T6G 2B7
email: Emily.cowley@albertahealthservices.ca
Funding: None received.

CJHP

•

Vol. 74, No. 1

•

Winter 2021    JCPH

•

Vol. 74, no 1

•

Hiver 2021

